Institution statistics

BAYER PHARMA AG - Germany

Ranking results:

Past rankings:

2015
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000
2014
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000
2011
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 11
As coordinator: 0
As participant: 11
Sole participant: 0
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2017	0	20.200.000	0		1
2016	0	21.085.937	0		2
2015	0	6.463.625	498.433		2
2014	0	4.000.000	400.000		1
2013	0	3.935.721	95.400		1
2011	0	12.766.589	638.857		3
2005	0	11.998.527	285.679		1

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
JANSSEN PHARMACEUTICA NV	4
MEDIZINISCHE UNIVERSITAET WIEN	4
GENOME RESEARCH	3
NOVARTIS PHARMA	3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	3
ABBVIE INC	2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS	2
ASTELLAS PHARMA EUROPE BV	2
ASTRAZENECA AB	2
CANCER RESEARCH UK	2
CHARITE UNIVERSITAETSMEDIZIN BERLIN	2
ELI LILLY AND COMPANY LIMITED	2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	2
F HOFFMANNLA ROCHE	2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR	2
HELSINGIN YLIOPISTO	2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	2
KAROLINSKA INSTITUTE	2
KATHOLIEKE UNIVERSITEIT LEUVEN	2
KUNGLIGA TEKNISKA HOEGSKOLAN	2
NOVO NORDISK	2
SANOFIAVENTIS DEUTSCHLAND	2
TAKEDA DEVELOPMENT CENTRE EUROPE	2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE	2
UNIVERSIDAD DE NAVARRA	2
UNIVERSITA DEGLI STUDI DI TORINO	2
UNIVERSITATSKLINIKUM ERLANGEN	2
UNIVERSITY COLLEGE LONDON	2
UNIVERSITY OF NEWCASTLE UPON TYNE	2
ABBVIE	1
ACADEMISCH ZIEKENHUIS GRONINGEN	1
ACTELION PHARMACEUTICALS	1
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS	1
ALMA MATER STUDIORUM UNIVERSITA DI BOLOGNA	1
AMGEN	1
AMGEN LIMITED	1
ARISTOTLE UNIVERSITY OF THESSALONIKI	1
ARTTIC IN BRUSSELS SPRL	1
ASSOCIATION POUR LA RECHERCHE DE THERAPEUTIQUES INNOVANTES EN CANCEROLOGIE	1
AVENTIS PHARMA RECHERCHEDEVELOPPEMENT	1
AXCENTUA PHARMACEUTICALS AB	1
BARTS AND THE LONDON NHS TRUST	1
BIOWISDOM LIMITED	1
BOEHRINGER INGELHEIM INTERNATIONALGMBH	1
BOEHRINGER INGELHEIM PHARMA GMBH & CO KG	1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE	1
CAPSANT NEUROTECHNOLOGIES	1
CELGENE MANAGEMENT SARL	1
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE	1
CEREBRICON	1
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL	1
CHU HOPITAUX DE BORDEAUX	1
CIPHERGEN BIOSYSTEMS INC	1
CONCENTRIS RESEARCH MANAGEMENT	1
CSL BEHRING	1
DANMARKS TEKNISKE UNIVERSITET	1
DEPARTMENT OF OLD AGE PSYCHIATRY & PSYCHOTIC DISORDERS MEDICAL UNIVERSITY OF LODZ	1
ELI LILLY AND COMPANY	1
ERASMUS UNIVERSITEIT ROTTERDAM	1
ERNSTMORITZARNDTUNIVERSITAET GREIFSWALD	1
EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL	1
EUROPEAN CANCER PATIENT COALITION	1
EUROPEAN FEDERATION FOR PHARMACEUTICAL SCIENCES	1
EUROPEAN FEDERATION OF BIOTECHNOLOGY	1
EUROPEAN FEDERATION OF PHARMACEUTICAL INDUSTRIES AND ASSOCIATIONS	1
EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION	1
EUROPEAN HEMATOLOGY ASSOCIATION	1
EUROPEAN MOLECULAR BIOLOGY LABORATORY	1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL	1
EUROPEAN PATIENTS' FORUM	1
EUROPEAN RESEARCH INITIATIVE ON CLL EV	1
EXPERIMENTAL PHARMACOLOGY AND ONCOLOGY BERLINBUCH	1
FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG	1
FONDAZIONE ITALIANA SINDROMI MIELODISPLASTICHE ETS	1
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS	1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON	1
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III	1
FUNDACION HOSPITAL LA FE	1
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON	1
GENEDATA	1
GILUPI	1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT	1
GMV SOLUCIONES GLOBALES INTERNET SAU	1
GPOH GEMEINNUTZIGE	1
GROUP FOR RESEARCH ON ADULT ACUTE LYMPHOBLASTIC LEUKEMIA	1
GROUPE FRANCOPHONE DES MYELODYSPLASIES	1
HACETTEPE UNIVERSITESI	1
HEINRICHHEINEUNIVERSITAET DUESSELDORF	1
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG	1
HORIZON DISCOVERY LIMITED	1
HUNTER FLEMING LIMITED	1
IKERLAN SCOOP	1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	1
INSTITUT CURIE	1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER	1
INSTITUT FUER PHOTONISCHE TECHNOLOGIEN EV	1
INSTITUT GUSTAVE ROUSSY	1
INSTITUTO DE MEDICINA MOLECULAR	1
INSTITUTO TUMORI ""GIOVANNI PAOLO II""	1
INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS	1

Constancy:

Total number of partners:227

Partner loyalty:
Frequent Partner: (> 2 projects): 17
Rare Partner: 210

Frequent / Rare Partner Ratio: 0.08

Diversity:

Subjects:

Subject:	No:
HEALTH	3
MEDICINE	3
LIFE SCIENCES	3
MEDICAL BIOTECHNOLOGY	2
MEDICINE, HEALTH	2
INFORMATION, MEDIA	1
COORDINATION	1
SCIENTIFIC RESEARCH	1
MEDIA	1
BIOTECHNOLOGY	1
COOPERATION	1
INFORMATION	1

Diversity index:0.39

Categories:

Category:	No:
BIOLOGICAL SCIENCES	5
RTD HORIZONTAL TOPICS	2
SOCIAL AND ECONOMIC CONCERNS	1

Project overview:

Start date	Project	acronym	role	funding	partners
2017-01-01	Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026	HARMONY	participant	20.200.000	53
2016-10-01	Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966	PREFER	participant	6.000.000	33
2016-09-01	Biomarker Enterprise to Attack DKD - Sofia ref.: 115974	BEAt-DKD	participant	15.085.937	31
2015-10-01	European Network linking informatics and genomics of helper T cells	ENLIGHT-TEN	participant	3.354.685	11
2015-01-01	Improving Design, Evaluation and Analysis of early drug development Studies	IDEAS	participant	3.108.939	8
2014-01-01	A CANcer Development mOnitor	CanDo	participant	4.000.000	10
2013-01-01	RADical reduction of OXidative stress in cardiovascular diseases	RADOX	participant	3.935.721	9
2011-10-01	Ion Transport Proteins in Control of Cancer Cell Behaviour	IonTraC	participant	3.925.580	10
2011-02-01	Targeting the tumour microenvironment to improve pancreatic cancer prognosis	EPC-TM-Net	participant	3.000.000	17
2011-01-01	Predicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics	PREDICT	participant	5.841.009	14
2005-10-01	Innovative medicines for europe	INNOMED	participant	11.998.527	42

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum